SC
JNJ icon

Stempoint Capital’s Johnson & Johnson JNJ Stock Holding History

Stempoint Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.77M Sell
15,415
-19,585
-56% -$4.56M 0.72% 42
2025
Q4 		$7.24M Buy
+35,000
New +$6.92M 1.24% 23
2024
Q1 		– Sell
-61,011
Closed -$9.56M – 78
2023
Q4 		$9.56M Buy
+61,011
New +$9.36M 2.55% 14

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Stempoint Capital's JNJ Position: Q1 2026 in Review

Stempoint Capital reduced its Johnson & Johnson (JNJ) stake by 56% in Q1 2026, selling an estimated $4.56M and leaving 15,415 shares worth $3.77M. The position accounts for 0.72% of the portfolio, ranked #42.

Stempoint Capital first reported a position in JNJ in Q4 2023 and has held it in 3 quarters since. The position peaked at $9.56M in Q4 2023. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Stempoint Capital held 15,415 shares of Johnson & Johnson worth $3.77M as of Q1 2026.
  • Stempoint Capital sold 19,585 Johnson & Johnson shares in Q1 2026, an estimated $4.56M.
  • Johnson & Johnson made up 0.72% of Stempoint Capital's portfolio in Q1 2026, its #42 holding.
  • Stempoint Capital first reported a position in Johnson & Johnson in Q4 2023 and has held it in 3 quarters since.
  • Stempoint Capital's Johnson & Johnson position peaked at $9.56M in Q4 2023.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Stempoint Capital's 13F filing for Q1 2026, filed 15 May 2026.